This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Kangstem Biotech Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Seung Hee Lee: Innovator in Cartilage Regeneration
Introduction
Seung Hee Lee is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of cartilage regeneration through his innovative research and patents. His work focuses on developing methods and compositions that promote cartilage differentiation, which is crucial for treating various arthropathies.
Latest Patents
Seung Hee Lee holds a patent for a complex designed to promote cartilage differentiation. This complex comprises stem cells or a culture thereof and a cartilage cell-free crush. The invention not only facilitates the differentiation of stem cells into cartilage cells without side effects in vivo but also enhances the regeneration of damaged cartilage through a paracrine effect. This innovative approach has the potential to be widely utilized in the treatment of arthropathies involving cartilage damage. He has 1 patent to his name.
Career Highlights
Seung Hee Lee is associated with Kangstem Biotech Co., Ltd., where he continues to advance his research in cartilage regeneration. His work has garnered attention for its potential applications in regenerative medicine and therapeutic interventions for joint diseases.
Collaborations
Seung Hee Lee collaborates with notable colleagues, including Kyung Sun Kang and Jong Chan Ahn. Their combined expertise contributes to the innovative research and development efforts at Kangstem Biotech Co., Ltd.
Conclusion
Seung Hee Lee's contributions to cartilage regeneration through his patented innovations highlight the importance of research in advancing medical treatments. His work not only addresses critical health issues but also paves the way for future advancements in regenerative medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile